Knott David M Jr Seagen Inc. Transaction History

Knott David M Jr

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $3.45 Million - $3.89 Million	18,000 New	18,000 $3.82 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $3.1 Million - $3.4 Million	16,500 New	16,500 $3.18 Million
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $637,950 - $1.02 Million	5,000 New	5,000 $1.01 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.